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Chronic Kidney Disease of Unknown aetiology is a signiﬁcant public health problem in Sri Lanka. The
ﬁnal report by the WHO mission recommended regulation of herbal medicines containing aristolochic
acid, which is an established nephrotoxin. The use of Complimentary and Alternative Medicine (CAM)
has a history of more than 2500 years in Sri Lanka. Aristolochia species are rarely used in Ayurveda and
traditional medicine in Sri Lanka. Before regulating the analysis of herbal preparations using Aristolochia,
collecting data from CAM practitioners regarding the use of Aristolochia is necessary. Analysis of Ayur-
veda pharmacopeia shows the doses used are negligible and some preparations are used for external
applications.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).The recent emergence and rapid spread of Chronic Kidney Dis-
ease of Unknown aetiology (CKDu) or Chronic Interstitial Nephritis
in Agricultural Communities (CINAC) in Sri Lanka necessitated
immediate action to identify the cause to control it. Several groups
hypothesized environmental toxins, including heavy metals found
in agrochemicals, as causative agents1,2 including the special
mission on CKDu appointed by the World Health Organization.3
The ﬁnal report by the WHO mission mentioned ten recommen-
dations to protect the public from CKDu.4 The sixth recommenda-
tion states “regulate the use of herbal medicines containing
aristolochic acid as it is an established nephrotoxin which has been
shown to cause kidney disease in other parts of the world”. This is
probably based on the fact that aristolochic acid, consumed in the
form of herbal products is associated with the Aristolochic acid
nephropathy.5 Chronic tubulo-interstitial nephropathy andrathne).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).
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016), http://dx.doi.org/10.10urothelial carcinoma seen in Balkan nephropathy is also associated
with aristolochic acid.6 In our view, linking of aristolochic acid
containing herbal medicine preparations to CKDu warrants further
discussion.
Sri Lankans from all geographical regions are using comple-
mentary and alternative medicine (CAM) since ancient times.7,8
Recent studies indicates 1.2e3% patients are seeking ayurvedic
treatment.9,10 The CKDu with increasing prevalence during the last
two decades causes signiﬁcant burden and seen mainly in the
North Central Province.2,3 Aristolochic acid is an alkaloid com-
pound naturally contained particularly in the genus Aristolochia.11
Various parts of the Aristolochia species have been used as anti-
inﬂammatory, diuretic and oedema reducing agents by practi-
tioners of the Chinese traditional medicine.11 Three species of
Aristolochia vines namely, indica, bracteolata, and ringens are found
in Sri Lanka.While Aristolochia indica and A. bracteolata (“Sapsanda”
in Sinhalese) are considered native to Sri Lanka, A. ringens was
introduced as an ornamental plant. Although both A. indica and
A. bractreolata are used as ingredients of medicinal preparations in
CAM systems in Asia, only A. indica is used in Ayurveda and tradi-
tional medicine in Sri Lanka. A. bractreolata is listed as a nearrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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medicine is questionable.12
Use of A. indica in standard Ayurvedic preparations in Sri Lanka
is sparse (personal communication with practitioners of Ayurveda)
and out of many hundreds of recipes in the Ayurveda pharmacopeia
published by the government of Sri Lanka, only ten preparations
contain ‘sapsanda’ (A. indica) as an ingredient (see Table 1).13 In the
list there are two “kashaya” (herbal decoction), one “kwatha”
(Alcohol based infusion) and six “thaila” (herbal oil) and one
“guliya” (herbal pill). Herbal oils are used mainly externally and
from the list of six herbal oils, four containing A. indica are used
both externally and internally. Despite being listed in the phar-
macopeia, the preparations recommended for internal use are not
commonly prescribed in the current practice of Ayurveda medicine
in Sri Lanka.
Traditional medical texts such as Vatikaprakaranaya claims of
many medicinal properties of A. indica including anti-
inﬂammatory, anti-microbial and anti-ulcer activities.14 ‘Sap-
sanda’ is mainly mentioned as an ingredient of herbal decoctions
and external applications used for snakebite management in the
indigenous system of medicine in Sri Lanka.15
Whenever Aristolochia species is used in Sri Lanka, it is an
ingredient of a poly-herbal compound rather than used as a single
herb. It is widely known that poly-herbal compounds which un-
dergo complex manufacturing processes may not unequivocally
possess the characteristics, qualities and undesired side effects of
the individual ingredients.16 Hence there is no established evidence
to suggest that whatever the poly-herbal compounds used in Sri
Lanka that contains Aristolochia as an ingredient, would have aris-
tolochic acid in considerable concentrations after processing.
Aristolochic acids are very polar compounds and therefore, theirTable 1
Ayurvedic herbal preparations.13
Name
(page in Ref. 9)
Preparation Contents Daily
Valu Kashaya (1)
Page 111
Decoction One out of
12 herbs
1.68 g
Valu kashaya (2)
Page 112
Decoction One out of
19 herbs
1.25 g
Vasa Musthakadi
kwathaya (1)
Page 112
Alcohol based infusion One out of
19 herbs
3.75 g
Abing Guliya
Page 140
Pill One of 23
ingredients
5.43 m
Yama Devaraja
Thailaya
Page 252
Herbal oil One out 54
ingredients
7.85 m
Maha Vayurakshasa
thailaya
Page 251
Herbal oil One out of
19 ingredients
62.5 m
Vishagarbha thailaya
Page 257
Herbal oil External use
only for
rheumatological
conditions
Neelaraja Thailaya
Page 241
Herbal oil One out of
31 ingredients
64.25
Navapatala Thailaya
Page 238
Herbal oil External use
only for headache,
migraine,
sinusitis and
eye diseases
Dashavaga prameha
thailaya
Page 236
Herbal oil One out of 65 6.9 m
a The daily dose is not mentioned in the pharmacopoeia. Dose is decided based on co
b The duration is not mentioned in the pharmacopeia. Duration is decided based on th
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used. Moreover, being a secondarymetabolite in plants, the amount
of aristolochic acid present in a unit weight of plant material de-
pends on a variety of factors such as the place where the plant was
growing (latitude, temperature etc.), age of the plant, plant parts
used, time and method of harvesting, storage conditions etc.17,18
Further there is no data on Ayurvedic and traditional medicines
used in Sri Lanka containing extracts of Aristolochia, being tested for
the presence of aristolochic acid. The presence of high amounts of
aristolochic acid in Aristolochia fangchi, used in slimming herbal
preparation consumed by Belgians,19 in A. manshuriensiswhich was
almost banned to be used in traditional Chinese medicine20 and in
A. clematitis which is hypothesized to be the cause of Balkan
endemic nephropathy21 does not imply the existence of similar risk
with A. indica in Sri Lanka. Even though the potential risks associ-
ated with the use of A. indicawas assessed, no cases of Aristolochic
acid nephropathy (AAN) have been reported in Bangladesh where
A. indica is widely available in herbal markets and through healers
networks.22
Oral intake of the cumulative doses above 200 g of herbal
preparations of Aristolochia for a mean duration of 15 months is
shown as a risk factor for urothelial carcinoma and for the devel-
opment of Aristolochic acid nephropathy, oral intake of cumulative
dose of aristolochia preparations over 150 g for a mean duration of
12 months is needed.23 Toxicity studies using animal models have
proved even very high doses (up to 3000 mg/kg) of ethanol extract
and 5000 mg/kg of aqueous root extract of A. indica as safe when
used for a short period.24,25
Even when used sparsely, CAM systems in Sri Lanka uses much
lower doses of Aristolochia preparations than known to be associ-
ated with tubulo-interstitial nephropathy or urothelial carcinoma.dose Recommended
duration
Total dose Indication
3 days 5 g Puerperal psychosis
3 daysb 3.75 g Puerperal psychosis
Few days
or one weekb
26.25 g Diarrheal infections
and sepsis
g Up to one weekb 38 mg Anti-helminthic
and in diarrhea
g Up to one weekb 55 mg External-nasal polyps
and tonsillitis.
Internal-diphtheria
and tonsillitis
g 3e4 daysb 250 mg Neurological disorders,
facial nerve palsy,
puerperal psychosis
cerebral oedema
mg Single doseb 64.3 mg Scorpion and snakebite
ga Two weeksb 96.6 mg Urinary tract disorders,
hemorrhoids, headaches
and neurological disorders
mmonly used doses in practice or as assumed by authors.
e general practices of using such drugs and the duration of illnesses that are treated.
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acid in an Ayurvedic herbal preparation is 26.25 g (Table 1). Further,
in CAM, exposure of patients to A. indica is likely to be of very short
term, particularly when used for snakebites. Extensive literature
search failed to locate a single clinical report of chronic kidney
disease from Sri Lanka, attributed to Aristolochia consumption from
CAM treatment or uroepithelial cancer associated with CKDu. A
publication that arose from the WHO study explicitly says that the
long-term use of herbal medicines was seen in a very small per-
centage of CKDu patients.3
Therefore, we argue that the available information is inadequate
to recommend regulation of the herbal preparation containing
aristolochic acid in Sri Lanka as a control measure of CKDu. We
further feel that caution should be practiced when such non-
evidence based recommendations are made in a country like Sri
Lanka where CAM systems are currently widely practiced and in
existence for more than 2500 years. This again emphasizes the need
for research into CAM systems that is integrated with (in this spe-
ciﬁc example) principals and philosophies of Ayurveda.26 Analyzing
the concentration of aristolochic acid, using reproducible, accurate
analytical methods, in herbal preparations using Aristolochia as one
of the ingredients, collecting data from drug manufactures and
Ayurveda practitioners regarding the use of Aristolochia in tradi-
tional medicine recipes other than Ayurveda pharmacopeia and
analyzing relevant clinical data to evaluate the relationship (if any)
between CKDu and aristolochic acid in Sri Lanka is a must.
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